{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:25:36Z","timestamp":1789586736468,"version":"build-2803163510"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:sec id=\"ab-hoi230060-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>High-sensitivity troponin tests can detect even milder cardiac troponin elevations in plasma, beyond the threshold of conventional troponin tests. Whether detection of low-grade cardiac troponin elevation is associated with outcomes of patients with hemodynamically stable pulmonary embolism (PE) and helps with risk stratification is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230060-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the association between high-sensitivity cardiac troponin I (hs-cTnI) compared with conventional cardiac troponin I (cTnI) and PE risk designations according to the European Society of Cardiology (ESC) 2019 classification scheme and clinical outcomes in patients with hemodynamically stable PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230060-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This is a post hoc analysis of data from the prospective Prognostic Value of Computed Tomography (PROTECT) multicenter cohort study enrolling patients from 12 hospital emergency departments in Spain. In this analysis, cTnI and hs-cTnI were compared with respect to ESC risk designation, and the association between troponin values and a complicated course after PE diagnosis was evaluated. Of 848 patients enrolled in PROTECT, 834 (98.3%) had hsTnI and cTnI values available and were included in the present analysis. Data were analyzed from May to December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230060-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Troponin blood testing with cTnI (threshold of &amp;amp;gt;0.05 ng\/mL) vs hs-cTnI (threshold of &amp;amp;gt;0.029 ng\/mL) assays at the time of PE diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230060-8\">\n                    <jats:title>Main Outcomes<\/jats:title>\n                    <jats:p>Complicated course, defined as hemodynamic collapse, recurrent PE, or all-cause death, within 30 days after PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230060-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 834 patients (mean [SEM] age, 67.5 [0.6] years; 424 [50.8%] female), 139 (16.7%) had elevated cTnI and 264 (31.7%) elevated hs-TnI, respectively. During follow-up, 62 patients (7.4%; 95% CI, 5.7-9.4) had a complicated course. Analyzing troponin elevation as a binary variable, elevated cTnI (odds ratio [OR], 2.84; 95% CI, 1.62-4.98) but not hs-cTnI (OR, 1.12; 95% CI, 0.65-1.93) was associated with increased odds of a complicated course. Of 125 patients who had elevated hs-cTnI but normal cTnI, none (0; 95% CI, 0.0-2.9) developed a complicated course. Using the 2019 ESC risk stratification scheme, hs-TnI classified fewer patients as low risk compared with cTnI. Among 78 patients designated as ESC low risk when using cTnI but not with hsTnI, none (0; 95% CI, 0.0-4.6) had a complicated course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230060-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study of patients with hemodynamically stable PE, hs-cTnI identified modest elevations in cardiac troponin levels. However, the results did not provide additive clinical value compared with cTnI. These findings suggest that use of hs-cTnI may result in overestimation of the risk in patients with stable PE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2023.4356","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:34:24Z","timestamp":1700652864000},"page":"64","source":"Crossref","is-referenced-by-count":38,"title":["High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism"],"prefix":"10.1001","volume":"9","author":[{"given":"Behnood","family":"Bikdeli","sequence":"first","affiliation":[{"name":"Cardiovascular Medicine Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Yale New Haven Hospital\/Yale Center for Outcomes Research and Evaluation, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Muriel","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit, Hospital Ram\u00f3n y Cajal and Universidad de Alcal\u00e1, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnifer","family":"Brice\u00f1o","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Mehdipoor","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Montefiore Medical Center and the Albert Einstein College of Medicine, The Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Piazza","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Ballaz","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital Galdakao, Galdakao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[{"name":"Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Yusen","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remedios","family":"Otero","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital Virgen del Roc\u00edo, Sevilla, Spain"},{"name":"Biomedical Research Networking Center Enfermedades Respiratorias, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital Ram\u00f3n y Cajal, Madrid, Spain"},{"name":"Biomedical Research Networking Center Enfermedades Respiratorias, Madrid, Spain"},{"name":"Medicine Department, Universidad de Alcal\u00e1, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"hoi230060r1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jacc.2021.01.011","article-title":"A test in context: interpretation of high-sensitivity cardiac troponin assays in different clinical settings.","volume":"77","author":"Raber","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi230060r2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ahj.2014.10.007","article-title":"Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis.","volume":"169","author":"Lipinski","year":"2015","journal-title":"Am Heart J"},{"issue":"9","key":"hoi230060r3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jacc.2018.12.046","article-title":"Recommendations for institutions transitioning to high-sensitivity troponin testing: JACC scientific expert panel.","volume":"73","author":"Januzzi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi230060r4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1055\/s-0038-1637746","article-title":"Performance of early prognostic assessment independently predicts the outcomes in patients with acute pulmonary embolism.","volume":"118","author":"Barbero","year":"2018","journal-title":"Thromb Haemost"},{"issue":"4","key":"hoi230060r5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"hoi230060r6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","article-title":"Derivation and validation of a prognostic model for pulmonary embolism.","volume":"172","author":"Aujesky","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"hoi230060r7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism.","volume":"170","author":"Jim\u00e9nez","year":"2010","journal-title":"Arch Intern Med"},{"issue":"24","key":"hoi230060r8","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1161\/CIRCULATIONAHA.111.051177","article-title":"Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study.","volume":"124","author":"Lankeit","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"hoi230060r9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1055\/s-0039-1698762","article-title":"Measurement of high-sensitivity cardiac troponin in pulmonary embolism: useful test or a clinical distraction.","volume":"45","author":"Lippi","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"hoi230060r10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11239-012-0709-7","article-title":"Prognostic significance of multidetector computed tomography in normotensive patients with pulmonary embolism: rationale, methodology and reproducibility for the PROTECT study.","volume":"34","author":"Jim\u00e9nez","year":"2012","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"hoi230060r11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/thoraxjnl-2012-202900","article-title":"Prognostic significance of multidetector CT in normotensive patients with pulmonary embolism: results of the protect study.","volume":"69","author":"Jim\u00e9nez","year":"2014","journal-title":"Thorax"},{"issue":"8","key":"hoi230060r12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/eurheartj\/ehr376","article-title":"Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays.","volume":"33","author":"Reiter","year":"2012","journal-title":"Eur Heart J"},{"issue":"11","key":"hoi230060r13","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1515\/cclm-2014-0107","article-title":"European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay.","volume":"52","author":"Krintus","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"22","key":"hoi230060r14","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi230060r15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.122.059678","article-title":"High-sensitivity cardiac troponin and the 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guidelines for the evaluation and diagnosis of acute chest pain.","volume":"146","author":"Sandoval","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"hoi230060r16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.121.055009","article-title":"Late outcomes of the RAPID-TnT Randomized Controlled Trial: 0\/1-hour high-sensitivity troponin T protocol in suspected ACS.","volume":"144","author":"Lambrakis","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"hoi230060r17","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1373\/clinchem.2012.192716","article-title":"Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population.","volume":"58","author":"Apple","year":"2012","journal-title":"Clin Chem"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2812275\/jamacardiology_bikdeli_2023_oi_230060_1703114485.72485.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T11:01:53Z","timestamp":1704884513000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2812275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.4356","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}